Suppr超能文献

利用侵袭性和携带分离株集合对脑膜炎奈瑟菌进行荚膜分型的表型和基因型方法比较

Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.

作者信息

Jones C Hal, Mohamed Naglaa, Rojas Eduardo, Andrew Lubomira, Hoyos Johanna, Hawkins Julio C, McNeil Lisa K, Jiang Qin, Mayer Leonard W, Wang Xin, Gilca Rodica, De Wals Philippe, Pedneault Louise, Eiden Joseph, Jansen Kathrin U, Anderson Annaliesa S

机构信息

Pfizer Vaccine Research and Development, Pearl River, New York, USA

Pfizer Vaccine Research and Development, Pearl River, New York, USA.

出版信息

J Clin Microbiol. 2016 Jan;54(1):25-34. doi: 10.1128/JCM.01447-15. Epub 2015 Aug 26.

Abstract

Neisseria meningitidis serogroup B (MnB) is a leading cause of bacterial meningitis; however, MnB is most commonly associated with asymptomatic carriage in the nasopharyngeal cavity, as opposed to the disease state. Two vaccines are now licensed for the prevention of MnB disease; a possible additional benefit of these vaccines could be to protect against disease indirectly by disrupting nasopharyngeal carriage (e.g., herd protection). To investigate this possibility, accurate diagnostic approaches to characterize MnB carriage isolates are required. In contrast to invasive meningococcal disease (IMD) isolates, which can be readily serogrouped, carriage isolates often lack capsule expression, making standard phenotypic assays unsuitable for strain characterization. Several antibody-based methods were evaluated for their abilities to serogroup isolates and were compared with two genotyping methods (real-time PCR [rt-PCR] and whole-genome sequencing [WGS]) to identify which approach would most accurately ascertain the polysaccharide groups associated with carriage isolates. WGS and rt-PCR were in agreement for 99% of IMD isolates, including those with coding sequences for MnB, MnC, MnW, and MnY, and the phenotypic methods correctly identified serogroups for 69 to 98% of IMD isolates. In contrast, only 47% of carriage isolates were groupable by genotypic methods, due to mutations within the capsule operon; of the isolates identified by genotypic methods, ≤43% were serogroupable with any of the phenotypic methods tested. These observations highlight the difficulties in the serogrouping and capsular genogrouping of meningococcal carriage isolates. Based on our findings, WGS is the most suitable approach for the characterization of meningococcal carriage isolates.

摘要

B群脑膜炎奈瑟菌(MnB)是细菌性脑膜炎的主要病因;然而,与疾病状态相反,MnB最常与鼻咽腔无症状携带相关。目前有两种疫苗被批准用于预防MnB疾病;这些疫苗的一个可能的额外益处可能是通过破坏鼻咽部携带间接预防疾病(例如群体保护)。为了研究这种可能性,需要准确的诊断方法来鉴定MnB携带分离株。与可容易进行血清群分型的侵袭性脑膜炎球菌病(IMD)分离株不同,携带分离株通常缺乏荚膜表达,使得标准表型检测不适用于菌株鉴定。评估了几种基于抗体的方法对分离株进行血清群分型的能力,并与两种基因分型方法(实时PCR [rt-PCR]和全基因组测序 [WGS])进行比较,以确定哪种方法能最准确地确定与携带分离株相关的多糖基团。WGS和rt-PCR对99%的IMD分离株结果一致,包括那些具有B群、C群、W群和Y群脑膜炎奈瑟菌编码序列的分离株,表型方法能正确鉴定69%至98%的IMD分离株的血清群。相比之下,由于荚膜操纵子内的突变,只有47%的携带分离株可通过基因分型方法进行分组;在通过基因分型方法鉴定的分离株中,≤43%可通过任何一种测试的表型方法进行血清群分型。这些观察结果凸显了脑膜炎球菌携带分离株血清群分型和荚膜基因分型的困难。基于我们的发现,WGS是鉴定脑膜炎球菌携带分离株最合适的方法。

相似文献

2
Carriage meningococcal isolates with capsule null locus dominate among high school students in a non-endemic period, Italy, 2012-2013.
Int J Med Microbiol. 2019 May-Jun;309(3-4):182-188. doi: 10.1016/j.ijmm.2019.03.004. Epub 2019 Mar 6.
3
Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.
J Clin Microbiol. 2012 Feb;50(2):264-73. doi: 10.1128/JCM.05385-11. Epub 2011 Nov 30.
4
Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort study.
Clin Microbiol Infect. 2017 Aug;23(8):573.e1-573.e7. doi: 10.1016/j.cmi.2017.02.008. Epub 2017 Feb 10.
7
Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil.
Vaccine. 2020 Mar 23;38(14):2995-3002. doi: 10.1016/j.vaccine.2020.02.050. Epub 2020 Feb 28.
9
Characterization of Carriage Isolates of Neisseria meningitides in the Adolescents and Young Adults Population of Bogota (Colombia).
PLoS One. 2015 Aug 31;10(8):e0135497. doi: 10.1371/journal.pone.0135497. eCollection 2015.

引用本文的文献

1
Development of a sequence-based OspA typing method for .
Microb Genom. 2024 May;10(5). doi: 10.1099/mgen.0.001252.
4
Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis.
Nat Rev Microbiol. 2020 Feb;18(2):84-96. doi: 10.1038/s41579-019-0282-6. Epub 2019 Nov 8.
6
Genomic analysis of Neisseria meningitidis carriage isolates during an outbreak of serogroup C clonal complex 11, Tuscany, Italy.
PLoS One. 2019 May 28;14(5):e0217500. doi: 10.1371/journal.pone.0217500. eCollection 2019.
10
RNA Thermometers in Bacterial Pathogens.
Microbiol Spectr. 2018 Apr;6(2). doi: 10.1128/microbiolspec.RWR-0012-2017.

本文引用的文献

1
Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011.
Can Commun Dis Rep. 2014 May 1;40(9):160-169. doi: 10.14745/ccdr.v40i09a01.
3
First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak.
Pediatrics. 2015 May;135(5):798-804. doi: 10.1542/peds.2014-4015.
4
Invasive meningococcal disease in the 21st century—an update for the clinician.
Curr Neurol Neurosci Rep. 2015 Mar;15(3):2. doi: 10.1007/s11910-015-0524-6.
5
Trumenba: a serogroup B meningococcal vaccine.
Med Lett Drugs Ther. 2015 Jan 5;57(1459):5-6.
6
The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.
Hum Vaccin Immunother. 2015;11(1):5-13. doi: 10.4161/hv.34293. Epub 2014 Nov 1.
9
A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.
Clin Infect Dis. 2014 Nov 1;59(9):1216-21. doi: 10.1093/cid/ciu601. Epub 2014 Jul 28.
10
The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.
Clin Infect Dis. 2014 Nov 1;59(9):1208-15. doi: 10.1093/cid/ciu597. Epub 2014 Jul 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验